ArticleScientific reports2025
An interpretable machine learning approach to prognosis of melioidosis pneumonia via computed tomography quantification and clinical data.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study aimed to develop a dataset comprising computed tomography (CT) images and clinical data for melioidosis pneumonia and to utilize machine learning for assisting in prognosis prediction of the disease. We retrospectively analyzed multicenter data from five hospitals to establish a dataset for diagnosing melioidosis pneumonia, including CT images and clinical data. An AI-based CT segmentation system was employed to extract lung tissue and lesions. Quantitative analysis methods were used to derive CT lesion characteristics specific to melioidosis pneumonia. Pearson and Spearman correlation tests were performed to examine the relationships between CT lesion characteristics and clinical parameters. Finally, a machine learning method was applied by combining CT lesion characteristics with clinical parameters to perform prognosis analysis, predicting the progression of melioidosis pneumonia patients to severe or critical illness. Correlation analysis revealed that lung injury was associated with clinical markers from other organ systems, indicating an interrelationship between lung lesions and systemic health. Using a multilayer perceptron classifier, which combined CT lesion characteristics with clinical parameters, the model predicted the progression to severe or critical illness with an AUC of 0.9570 (95% CI: 0.9262-0.9816). This study demonstrated that the CT lesion characteristics of melioidosis pneumonia are correlated with indicators of multi-organ function. Combining CT lesion characteristics with clinical parameters improves the efficiency of prognosis prediction for melioidosis pneumonia. Lung injury CT lesion characteristics were identified as primary markers for predicting the disease prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.